NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from HK Peptides? Mail in a sample (US only) and let us test it.

Test my supply
+5 more ↓
74%
Finnrick rating
#174 of 345 ranked vendors
351 of 452 classifiable tests passed
methodology · Purity focus
Finnrick analysis

HK Peptides shows its strongest purity-focus evidence in Retatrutide, Tirzepatide, and GHK-Cu, where large recent records offset but do not erase earlier identity, purity, and fill failures. Results are dispersed rather than steady: Tesamorelin, CJC-1295, Ipamorelin, and TB-500 carry repeated misses, while many rows lack batch IDs.

methodology →
vendor intelligence report
Vendor Intelligence Report: HK Peptides

Corporate records and homepage evidence point past the Hong Kong branding to a mainland operating trail and a separate manufacturing-facing domain with verification friction. The report maps the HKMS PEP/HPT adjacency, copycat domains, crypto payment rails, and forum impersonation signals.

26 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$1.00
86%
142
2
GHK-Cu
$0.07
86%
49
3
Tirzepatide
$0.47
83%
130
4
BPC-157
$0.82
78%
22
5
PT-141
-
75%
7
6
Melanotan II
$0.41
69%
12
7
Semaglutide
$0.70
65%
10
8
Cagrilintide
$2.30
60%
11
9
Ipamorelin
$0.81
59%
13
10
Tesamorelin
$1.78
47%
34
11
Sermorelin
$1.57
45%
6
12
TB-500
$1.76
43%
10
13
CJC-1295
$1.90
29%
10
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%8 May 2026: 74%8 May 2026: 74%19 May 2026: 74%1 Jun 2026: 74%8 Jun 2026: 74%12 Jun 2026: 74%12 Jun 2026: 74%12 Jun 2026: 74%12 Jun 2026: 74%16 Jun 2026: 74%22 Jun 2026: 74%9 Jul 2026: 75%9 Jul 2026: 74%13 Jul 2026: 75%13 Jul 2026: 75%20 Jul 2026: 75%20 Jul 2026: 74%20 Jul 2026: 74%3 Aug 2026: 75%3 Aug 2026: 75%3 Aug 2026: 75%3 Aug 2026: 75%12 Aug 2026: 75%13 Aug 2026: 75%26 Aug 2026: 75%26 Aug 2026: 75%26 Aug 2026: 75%26 Aug 2026: 75%26 Aug 2026: 75%28 Aug 2026: 75%28 Aug 2026: 74%28 Aug 2026: 74%28 Aug 2026: 74%28 Aug 2026: 74%4 Sept 2026: 74%9 Sept 2026: 74%9 Sept 2026: 74%9 Sept 2026: 74%10 Sept 2026: 73%14 Sept 2026: 74%22 Sept 2026: current 74%74%75%74%May 26Sep 26
Free peptide testing

Ordered peptides from HK Peptides? Mail in a sample (US only) and let us test it.

Test my supply
HK Peptides test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
14 Sep 2026
Pass
Retatrutide
lab nameView COA
10 Sep 2026
Fail
TB-500
lab nameView COA
9 Sep 2026
Pass
Retatrutide
lab nameView COA
9 Sep 2026
Fail
Retatrutide
lab nameView COA
9 Sep 2026
Pass
BPC-157
lab nameView COA
4 Sep 2026
Fail
Sermorelin
lab nameView COA
28 Aug 2026
Fail
Tirzepatide
lab nameView COA
28 Aug 2026
Fail
Tirzepatide
lab nameView COA
28 Aug 2026
Fail
Tirzepatide
lab nameView COA
28 Aug 2026
Fail
Cagrilintide
lab nameView COA
1-10 of 200

About HK Peptides test results from Finnrick

HK Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 13 peptides and 456 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible HK Peptides peptides in this dataset are BPC-157 (22 tests) and Melanotan II (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from HK Peptides? Mail in a sample (US only) and let us test it.

Test my supply